Wedbush Maintains Underperform on Praxis Precision Medicine, Raises Price Target to $189
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $188 to $189.
Wedbush analyst Laura Chico maintains Praxis Precision Medicine (NASDAQ:PRAX) with a Underperform and raises the price target from $188 to $189.